title: A review of nerve agent exposure for the critical care physician.
abstract: Nerve agents are discussed. The article discusses their properties, routes of exposure, toxicodynamics, targets of toxicity, and treatment. It is concluded that a focused organized approach to the treatment of nerve agents is key to its successful management.
authors.affiliation: Evanston Northwestern Healthare OMEGA, Glenbrook Hospital, Glenview, IL, USA. jleikin@enh.org
authors.forename: Jerrold B
authors.initials: JB
authors.lastname: Leikin
authors.forename: Richard G
authors.initials: RG
authors.lastname: Thomas
authors.forename: Frank G
authors.initials: FG
authors.lastname: Walter
authors.forename: Raymond
authors.initials: R
authors.lastname: Klein
authors.forename: Harvey W
authors.initials: HW
authors.lastname: Meislin
mesh_terms: D000931:Antidotes / Q000627:therapeutic use; D002619:Chemical Warfare Agents / Q000737:chemistry / Q000506:poisoning; D002800:Cholinesterase Inhibitors / Q000737:chemistry / Q000506:poisoning; D003666:Decontamination / Q000379:methods; D006801:Humans; D009420:Nervous System / Q000187:drug effects; D062025:Organophosphate Poisoning; D010755:Organophosphates / Q000737:chemistry; D009946:Organothiophosphorus Compounds / Q000737:chemistry / Q000506:poisoning; D012524:Sarin / Q000737:chemistry / Q000506:poisoning; D012999:Soman / Q000737:chemistry / Q000506:poisoning
chemical_list: D000931:Antidotes; D002619:Chemical Warfare Agents; D002800:Cholinesterase Inhibitors; D010755:Organophosphates; D009946:Organothiophosphorus Compounds; D012524:Sarin; D012999:Soman; C009680:VX-agent; C009374:tabun